ARTHROPLASTY
Addition of IV parecoxib to femoral nerve block in TKA reduces pain compared to placebo
Pain Physician. 2015 May-Jun;18(3):267-7690 patients scheduled to undergo total knee arthroplasty (TKA) with continuous femoral nerve block were randomized to receive either intravenous parecoxib or placebo administration. Visual analog scale (VAS) pain scores were assessed at 4, 8, 12, 24, and 36 hours. Findings demonstrated significantly lower pain over 36 hours postoperatively in the parecoxib group as compared to the placebo group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
